CMIC：2024年通过全球CRO合作关系转变非临床开发报告（英文版）

The life sciences industry continues to experience high levels of innovation, regulation, and competition, all of which contribute to an increasing reliance on non-clinical trials to guide R&D strategy. Determining efficacy, toxicity, and safety of a novel drug prior to clinical development helps inform organizations about a drug’s potential success before making the decision to invest significant time and resources. However, the non-clinical trial landscape has challenges of its own. New